Drug Discovery Services Market Projected to Reach $75.13 Billion by 2034

The global drug discovery services market is currently valued at $22.04 billion in 2025 and is anticipated to generate an estimated revenue of $75.13 billion by 2034. The market exhibits a robust 14.6% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026-2034.

The drug discovery and development services markets are projected to experience substantial growth during the forecast period from 2026 to 2033. In 2026, the market is expected to expand steadily, with major players increasingly adopting strategic initiatives to drive growth beyond initial forecasts. The growth is supported by rising industry demand, expanding applications, and ongoing technological advancements.

Key players in the drug discovery services market include Charles River Laboratories International, Inc., Covance Inc. (part of Labcorp), ICON plc, Syngene International Ltd., WuXi AppTec Co., Ltd., Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher Scientific), Eurofins Scientific, GVK Biosciences, Jubilant Biosys, Evotec SE, Medpace Holdings, Inc., TCG Lifesciences, Pharmaron Beijing Co., Ltd., Frontage Laboratories, Inc., and Selvita S.A.

The drug development services market includes major players such as Parexel International, Syneos Health, PRA Health Sciences, Thermo Fisher Scientific, Catalent, and Quintiles IMS.

The market is segmented by process into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. By type, the market is divided into chemistry services and biology services. Drug type segmentation includes small molecules and biologics.

Therapeutic area segmentation covers oncology, infectious diseases, cardiovascular diseases, neurological diseases, immunological diseases, digestive and gastrointestinal diseases, genitourinary and women's health, respiratory diseases, endocrine and metabolic diseases, and other therapeutic areas. End users include pharmaceutical and biotechnology companies, academic institutes, and others.

The drug discovery market by technology includes high throughput screening, biochips, bioinformatics, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics, and other technologies. Services encompass drug metabolism and pharmacokinetics (DMPK) services, pharmaceutical services, chemical services, and biological services.

Key regions covered include North America (United States, Canada, and Mexico), Europe (Germany, U.K., France, Russia, Italy, Spain), Asia-Pacific (China, India, Japan, Australia, Singapore, New Zealand), South America (Argentina, Brazil), and Middle East & Africa (Saudi Arabia, Turkey, UAE, Africa).